Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Consumption of Pep19 on Quality of Life

NCT06359327 is registered in ClinicalTrials.gov with Proteimax Biotechnology Israel LTD as lead sponsor.

NCT NCT06359327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Consumption of Pep19 on Quality of Life
Lead sponsor
Proteimax Biotechnology Israel LTD
Phase
Not applicable
Overall status
Completed
Start date
May 28, 2024
Completion date
August 15, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, quality of life, sleep quality